The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of ≤12 months

Matthew A. Lunning, Jocelyn C. Migliacci, Patrick Hilden, Sean M. Devlin, Hugo Castro-Malaspina, Sergio Giralt, Miguel Angel Perales, Andrew D. Zelenetz, Craig Moskowitz, Craig S. Sauter

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Early relapsed or refractory follicular lymphoma (FL) warrants consolidation with transplantation, though graft source modality remains controversial. We analysed the outcomes of 44 patients transplanted with either autologous or allogeneic graft sources in the post-rituximab era. No difference in event-free (EFS) or overall survival (OS) was observed between allogeneic (81% and 81%) and autologous transplantation (64% and 70%) at 3 years. There was a significant difference in EFS between allogeneic and autologous transplantation patients with previous remission duration of ≤12 months (80% and 42% at 3 years, P < 0·015). Very early relapsed FL may warrant consideration of allogeneic over autologous transplantation in the appropriate setting.

Original languageEnglish (US)
Pages (from-to)260-264
Number of pages5
JournalBritish Journal of Haematology
Volume173
Issue number2
DOIs
StatePublished - Apr 1 2016
Externally publishedYes

Fingerprint

Follicular Lymphoma
Autologous Transplantation
Transplants
Homologous Transplantation
Transplantation
Survival

Keywords

  • Follicular lymphoma
  • Non-Hodgkin lymphoma
  • Stem cell transplantation

ASJC Scopus subject areas

  • Hematology

Cite this

The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of ≤12 months. / Lunning, Matthew A.; Migliacci, Jocelyn C.; Hilden, Patrick; Devlin, Sean M.; Castro-Malaspina, Hugo; Giralt, Sergio; Perales, Miguel Angel; Zelenetz, Andrew D.; Moskowitz, Craig; Sauter, Craig S.

In: British Journal of Haematology, Vol. 173, No. 2, 01.04.2016, p. 260-264.

Research output: Contribution to journalArticle

Lunning, Matthew A. ; Migliacci, Jocelyn C. ; Hilden, Patrick ; Devlin, Sean M. ; Castro-Malaspina, Hugo ; Giralt, Sergio ; Perales, Miguel Angel ; Zelenetz, Andrew D. ; Moskowitz, Craig ; Sauter, Craig S. / The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of ≤12 months. In: British Journal of Haematology. 2016 ; Vol. 173, No. 2. pp. 260-264.
@article{aba32d6613a44ed6be5bae72357bb1c2,
title = "The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of ≤12 months",
abstract = "Early relapsed or refractory follicular lymphoma (FL) warrants consolidation with transplantation, though graft source modality remains controversial. We analysed the outcomes of 44 patients transplanted with either autologous or allogeneic graft sources in the post-rituximab era. No difference in event-free (EFS) or overall survival (OS) was observed between allogeneic (81{\%} and 81{\%}) and autologous transplantation (64{\%} and 70{\%}) at 3 years. There was a significant difference in EFS between allogeneic and autologous transplantation patients with previous remission duration of ≤12 months (80{\%} and 42{\%} at 3 years, P < 0·015). Very early relapsed FL may warrant consideration of allogeneic over autologous transplantation in the appropriate setting.",
keywords = "Follicular lymphoma, Non-Hodgkin lymphoma, Stem cell transplantation",
author = "Lunning, {Matthew A.} and Migliacci, {Jocelyn C.} and Patrick Hilden and Devlin, {Sean M.} and Hugo Castro-Malaspina and Sergio Giralt and Perales, {Miguel Angel} and Zelenetz, {Andrew D.} and Craig Moskowitz and Sauter, {Craig S.}",
year = "2016",
month = "4",
day = "1",
doi = "10.1111/bjh.13947",
language = "English (US)",
volume = "173",
pages = "260--264",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of ≤12 months

AU - Lunning, Matthew A.

AU - Migliacci, Jocelyn C.

AU - Hilden, Patrick

AU - Devlin, Sean M.

AU - Castro-Malaspina, Hugo

AU - Giralt, Sergio

AU - Perales, Miguel Angel

AU - Zelenetz, Andrew D.

AU - Moskowitz, Craig

AU - Sauter, Craig S.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Early relapsed or refractory follicular lymphoma (FL) warrants consolidation with transplantation, though graft source modality remains controversial. We analysed the outcomes of 44 patients transplanted with either autologous or allogeneic graft sources in the post-rituximab era. No difference in event-free (EFS) or overall survival (OS) was observed between allogeneic (81% and 81%) and autologous transplantation (64% and 70%) at 3 years. There was a significant difference in EFS between allogeneic and autologous transplantation patients with previous remission duration of ≤12 months (80% and 42% at 3 years, P < 0·015). Very early relapsed FL may warrant consideration of allogeneic over autologous transplantation in the appropriate setting.

AB - Early relapsed or refractory follicular lymphoma (FL) warrants consolidation with transplantation, though graft source modality remains controversial. We analysed the outcomes of 44 patients transplanted with either autologous or allogeneic graft sources in the post-rituximab era. No difference in event-free (EFS) or overall survival (OS) was observed between allogeneic (81% and 81%) and autologous transplantation (64% and 70%) at 3 years. There was a significant difference in EFS between allogeneic and autologous transplantation patients with previous remission duration of ≤12 months (80% and 42% at 3 years, P < 0·015). Very early relapsed FL may warrant consideration of allogeneic over autologous transplantation in the appropriate setting.

KW - Follicular lymphoma

KW - Non-Hodgkin lymphoma

KW - Stem cell transplantation

UR - http://www.scopus.com/inward/record.url?scp=84957676400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957676400&partnerID=8YFLogxK

U2 - 10.1111/bjh.13947

DO - 10.1111/bjh.13947

M3 - Article

C2 - 26847389

AN - SCOPUS:84957676400

VL - 173

SP - 260

EP - 264

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 2

ER -